JP2005508905A5 - - Google Patents

Download PDF

Info

Publication number
JP2005508905A5
JP2005508905A5 JP2003528544A JP2003528544A JP2005508905A5 JP 2005508905 A5 JP2005508905 A5 JP 2005508905A5 JP 2003528544 A JP2003528544 A JP 2003528544A JP 2003528544 A JP2003528544 A JP 2003528544A JP 2005508905 A5 JP2005508905 A5 JP 2005508905A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
heterocycle
acceptable salt
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003528544A
Other languages
English (en)
Japanese (ja)
Other versions
JP3795044B2 (ja
JP2005508905A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/029017 external-priority patent/WO2003024448A2/en
Publication of JP2005508905A publication Critical patent/JP2005508905A/ja
Publication of JP2005508905A5 publication Critical patent/JP2005508905A5/ja
Application granted granted Critical
Publication of JP3795044B2 publication Critical patent/JP3795044B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003528544A 2001-09-14 2002-09-12 ヒストンデアセチラーゼの阻害剤 Expired - Fee Related JP3795044B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US32240201P 2001-09-14 2001-09-14
US39172802P 2002-06-26 2002-06-26
PCT/US2002/029017 WO2003024448A2 (en) 2001-09-14 2002-09-12 Inhibitors of histone deacetylase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005080310A Division JP2005255683A (ja) 2001-09-14 2005-03-18 ヒストンデアセチラーゼの阻害剤

Publications (3)

Publication Number Publication Date
JP2005508905A JP2005508905A (ja) 2005-04-07
JP2005508905A5 true JP2005508905A5 (OSRAM) 2005-12-22
JP3795044B2 JP3795044B2 (ja) 2006-07-12

Family

ID=26983397

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2003528544A Expired - Fee Related JP3795044B2 (ja) 2001-09-14 2002-09-12 ヒストンデアセチラーゼの阻害剤
JP2005080310A Pending JP2005255683A (ja) 2001-09-14 2005-03-18 ヒストンデアセチラーゼの阻害剤
JP2010013418A Abandoned JP2010168382A (ja) 2001-09-14 2010-01-25 ヒストンデアセチラーゼの阻害剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2005080310A Pending JP2005255683A (ja) 2001-09-14 2005-03-18 ヒストンデアセチラーゼの阻害剤
JP2010013418A Abandoned JP2010168382A (ja) 2001-09-14 2010-01-25 ヒストンデアセチラーゼの阻害剤

Country Status (10)

Country Link
US (1) US7595343B2 (OSRAM)
EP (1) EP1429765A2 (OSRAM)
JP (3) JP3795044B2 (OSRAM)
KR (2) KR20100107509A (OSRAM)
CN (2) CN101851173A (OSRAM)
AU (1) AU2002327627B2 (OSRAM)
BR (1) BR0212510A (OSRAM)
CA (1) CA2465978C (OSRAM)
MX (1) MXPA04002397A (OSRAM)
WO (1) WO2003024448A2 (OSRAM)

Families Citing this family (186)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
US7868204B2 (en) 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
CA2465978C (en) 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
AU2003244463A1 (en) 2002-02-05 2003-09-02 Yamanouchi Pharmaceutical Co., Ltd. 2,4,6-triamino-1,3,5-triazine derivative
TWI319387B (en) * 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0209715D0 (en) * 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7351719B2 (en) 2002-10-31 2008-04-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds
CA2518318A1 (en) 2003-03-17 2004-09-30 Takeda San Diego, Inc. Histone deacetylase inhibitors
DE10323345A1 (de) 2003-05-23 2004-12-16 Zentaris Gmbh Neue Pyridopyrazine und deren Verwendung als Kinase-Inhibitoren
ME00541B (me) 2003-05-23 2011-10-10 Zentaris Gmbh NOVI PIRIDOPIRAZINI I NJlUHOVA UPOTREBA KAO MODULATORA KlNAZA
CA2532965C (en) 2003-07-22 2013-05-14 Astex Therapeutics Limited 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators
CA2536313A1 (en) * 2003-08-22 2005-03-03 Takeda Pharmaceutical Company Limited Fused pyrimidine derivative and use thereof
WO2005030705A1 (en) 2003-09-24 2005-04-07 Methylgene, Inc. Inhibitors of histone deacetylase
GB0322409D0 (en) * 2003-09-25 2003-10-29 Astrazeneca Ab Quinazoline derivatives
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
JP4667384B2 (ja) 2003-10-07 2011-04-13 レノビス， インコーポレイテッド イオンチャネルリガンドとしてのアミド誘導体および薬学的組成物、ならびにこれらを使用する方法
WO2005034880A2 (en) * 2003-10-09 2005-04-21 Aton Pharma, Inc. Thiophene and benzothiophene hydroxamic acid derivatives
CA2542329A1 (en) 2003-10-16 2005-04-28 Chiron Corporation 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
US20050159470A1 (en) * 2003-12-19 2005-07-21 Syrrx, Inc. Histone deacetylase inhibitors
WO2005066151A2 (en) * 2003-12-19 2005-07-21 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7592373B2 (en) 2003-12-23 2009-09-22 Boehringer Ingelheim International Gmbh Amide compounds with MCH antagonistic activity and medicaments comprising these compounds
EP1715855A4 (en) * 2004-01-29 2010-06-16 Elixir Pharmaceuticals Inc ANTIVIRAL DRUGS
JP2007519754A (ja) * 2004-01-30 2007-07-19 スミスクライン ビーチャム コーポレーション 化合物
EP2272827A1 (en) 2004-03-11 2011-01-12 4Sc Ag Sulphonylpyrroles as hdac inhibitors
TWI415606B (zh) * 2004-03-26 2013-11-21 Methylgene Inc 組蛋白去乙醯基酶之抑制劑
WO2005092899A1 (en) * 2004-03-26 2005-10-06 Methylgene Inc. Inhibitors of histone deacetylase
US7253204B2 (en) * 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
NZ551027A (en) 2004-04-08 2011-01-28 Targegen Inc Benzotriazine inhibitors of kinases
AR050926A1 (es) * 2004-09-03 2006-12-06 Astrazeneca Ab Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
US7776869B2 (en) 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
EP1824831A2 (en) 2004-12-16 2007-08-29 Takeda San Diego, Inc. Histone deacetylase inhibitors
GB0501146D0 (en) * 2005-01-20 2005-02-23 Astrazeneca Ab Novel benzamide derivatives
AR054425A1 (es) 2005-01-21 2007-06-27 Astex Therapeutics Ltd Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
US8404718B2 (en) 2005-01-21 2013-03-26 Astex Therapeutics Limited Combinations of pyrazole kinase inhibitors
KR20070097590A (ko) 2005-01-25 2007-10-04 에픽스 델라웨어, 인코포레이티드 치환된 아릴아민 화합물 및 5―ｈｔ6 조절제로서의 이의용도
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
EA015533B1 (ru) 2005-03-15 2011-08-30 4Сц Аг N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
CA2603947A1 (en) 2005-04-20 2006-11-02 Merck & Co., Inc. Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutions
WO2006115835A2 (en) * 2005-04-20 2006-11-02 Merck & Co., Inc. Benzothiophene hydroxamic acid derivatives
AU2006240258A1 (en) 2005-04-20 2006-11-02 Merck Sharp & Dohme Corp. Benzothiophene derivatives
JP2008540574A (ja) * 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
CA2608463C (en) * 2005-05-19 2015-02-03 Prometic Biosciences Inc. Compounds, compositions containing such compounds, and methods of treatment of metastatic melanoma and other cancers
KR101378716B1 (ko) 2005-05-20 2014-04-10 메틸진 인코포레이티드 Ｖｅｇｆ 수용체 및 ｈｇｆ 수용체 신호전달의 억제제
US7417066B2 (en) 2005-06-08 2008-08-26 Schering Ag Inhibitors of soluble adenylate cyclase
DE102005027274A1 (de) * 2005-06-08 2006-12-14 Schering Ag Inhibitoren der löslichen Adenylatzyklase
EP1890703B1 (en) 2005-06-14 2016-05-11 Taigen Biotechnology Pyrimidine compounds as chemokine receptors inhibitors
US8193206B2 (en) 2005-06-14 2012-06-05 Taigen Biotechnology Co., Ltd. Pyrimidine compounds
JP4528918B2 (ja) * 2005-06-21 2010-08-25 学校法人 関西大学 カルボキサミド誘導体
US8158825B2 (en) 2005-06-24 2012-04-17 Merck Sharp & Dohme Corp. Modified malonate derivatives
CN101263121A (zh) 2005-07-14 2008-09-10 塔克达圣地亚哥公司 组蛋白脱乙酰基酶抑制剂
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CN101287706A (zh) 2005-09-21 2008-10-15 尼科梅德有限责任公司 作为组蛋白脱乙酰基酶抑制剂的磺酰基吡咯盐酸盐
EP1928872B1 (en) 2005-09-21 2012-03-14 4Sc Ag Novel sulphonylpyrroles as inhibitors of hdac
GB0521244D0 (en) 2005-10-19 2005-11-30 Astrazeneca Ab Benzamide compounds
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス，インコーポレイティド Ｐｄｅ阻害による神経新生の調節
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
MY167260A (en) 2005-11-01 2018-08-14 Targegen Inc Bi-aryl meta-pyrimidine inhibitors of kinases
EP1790342A1 (de) 2005-11-11 2007-05-30 Zentaris GmbH Pyridopyrazin-Derivate und deren Verwendung als Modulatoren der Signaltransduktionswege
US8217042B2 (en) 2005-11-11 2012-07-10 Zentaris Gmbh Pyridopyrazines and their use as modulators of kinases
KR101400905B1 (ko) 2005-11-11 2014-05-29 아에테르나 젠타리스 게엠베하 신규한 피리도피라진 및 키나제의 조절제로서의 이의 용도
AR057579A1 (es) 2005-11-23 2007-12-05 Merck & Co Inc Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
AU2007221207A1 (en) 2006-02-28 2007-09-07 Merck Sharp & Dohme Corp. Inhibitors of histone deacetylase
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP5554988B2 (ja) 2006-04-07 2014-07-23 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤
CA2649861A1 (en) 2006-04-26 2007-11-08 Merck & Co., Inc. Disubstituted aniline compounds
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US8119652B2 (en) 2006-05-18 2012-02-21 Merck Sharp & Dohme Corp. Aryl-fused spirocyclic compounds
US7981874B2 (en) 2006-07-20 2011-07-19 Merck Sharp & Dohme Corp. Phosphorus derivatives as histone deacetylase inhibitors
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
CA2667826C (en) 2006-10-28 2013-10-08 Methylgene Inc. Inhibitors of histone deacetylase
JP5622393B2 (ja) 2006-12-15 2014-11-12 アブラクシスバイオサイエンス リミテッド ライアビリティー カンパニー トリアジン誘導体類及びそれらの治療応用
JP2010519328A (ja) 2007-02-26 2010-06-03 ファイザー・プロダクツ・インク Ｈ−ｐｇｄｓの阻害剤としてのニコチンアミド誘導体およびプロスタグランジンｄ２が媒介する疾患の治療のためのそれらの使用
US8030344B2 (en) * 2007-03-13 2011-10-04 Methylgene Inc. Inhibitors of histone deacetylase
AU2008269154B2 (en) 2007-06-27 2014-06-12 Merck Sharp & Dohme Llc 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
WO2009005638A2 (en) 2007-06-27 2009-01-08 Merck & Co., Inc. Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
JP5322477B2 (ja) * 2007-09-28 2013-10-23 富士フイルム株式会社 新規アセチレン化合物、その塩、その製造方法、それを構成単位として含むポリマー、該ポリマーの製造方法、該ポリマーの組成物、該ポリマー組成物を硬化させてなる硬化物
AU2008300827B2 (en) 2007-09-19 2013-04-04 4Sc Ag Novel tetrahydrofusedpyridines as histone deacetylase inhibitors
EP2195296A1 (en) 2007-09-27 2010-06-16 F. Hoffmann-Roche AG Quinoline derivatives as 5ht5a receptor antagonists
EP2205563A4 (en) * 2007-10-10 2012-01-25 Orchid Res Lab Ltd NEW HISTONDEACETYLASE INHIBITORS
JP2011500783A (ja) * 2007-10-22 2011-01-06 オーキッド リサーチ ラボラトリーズ リミテッド ヒストンデアセチラーゼ阻害剤
EP2060565A1 (en) * 2007-11-16 2009-05-20 4Sc Ag Novel bifunctional compounds which inhibit protein kinases and histone deacetylases
JP2011510917A (ja) * 2008-01-29 2011-04-07 エフ．ホフマン−ラ ロシュ アーゲー 新規ｎ−（２−アミノ−フェニル）−アミド誘導体
PL2268635T3 (pl) 2008-04-21 2015-11-30 Taigen Biotechnology Co Ltd Związki heterocykliczne
EP2280940A1 (en) * 2008-05-16 2011-02-09 F. Hoffmann-La Roche AG Novel n-(2-amino-phenyl)-acrylamides
ES2554513T3 (es) 2008-05-23 2015-12-21 Novartis Ag Derivados de quinolinas y quinoxalinas como inhibidores de la proteína tirosina quinasa
PL2292611T3 (pl) 2008-05-23 2012-11-30 Santen Pharmaceutical Co Ltd Nowa pochodna tiofenodiaminy mająca strukturę mocznikową
US8445491B2 (en) 2008-05-27 2013-05-21 The Board Of Regents Of The University Of Texas System Wnt protein signalling inhibitors
ES2620027T3 (es) 2008-09-03 2017-06-27 Biomarin Pharmaceutical Inc. Composiciones que incluyen derivados del ácido 6-aminohexanoico como inhibidores de HDAC
US8202866B2 (en) * 2008-09-17 2012-06-19 Hoffmann-La Roche Inc. Ortho-aminoanilides for the treatment of cancer
PL2356109T3 (pl) * 2008-10-10 2017-07-31 Vm Discovery, Inc. Kompozycje i sposoby leczenia zaburzeń używania alkoholu, bólu i innych chorób
US8293897B2 (en) 2008-10-14 2012-10-23 Ning Xi Compounds comprising a spiro-ring and methods of use
TW201021855A (en) 2008-11-13 2010-06-16 Taigen Biotechnology Co Ltd Lyophilization formulation
US8748623B2 (en) * 2009-02-17 2014-06-10 Syntrix Biosystems, Inc. Pyridinecarboxamides as CXCR2 modulators
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
CN101906076B (zh) * 2009-06-04 2013-03-13 深圳微芯生物科技有限责任公司 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用
KR20120026611A (ko) * 2009-06-09 2012-03-19 아브락시스 바이오사이언스, 엘엘씨 헷지호그 신호전달의 피리딜-트리아진 억제제
BRPI1011319A2 (pt) 2009-06-09 2016-06-21 California Capital Equity Llc derivados de triazina benzil-substituídos e suas aplicações terapêuticas
AU2010258853B2 (en) 2009-06-09 2014-07-31 Nantbio, Inc. Triazine derivatives and their therapeutical applications
US8784873B2 (en) * 2009-07-22 2014-07-22 Naturewise Biotech & Medicals Corporation Use of histone deacetylase inhibitors in changing MRJP3 protein in royal jelly
JP2011057661A (ja) * 2009-08-14 2011-03-24 Bayer Cropscience Ag 殺虫性カルボキサミド類
NZ599757A (en) 2009-10-30 2014-08-29 Massachusetts Inst Technology The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
WO2011144742A1 (en) 2010-05-21 2011-11-24 Chemilia Ab Novel pyrimidine derivatives
US8779149B2 (en) * 2010-08-23 2014-07-15 Syntrix Biosystems, Inc. Aminopyridine- and aminopyrimidinecarboxamides as CXCR2 modulators
WO2012060847A1 (en) 2010-11-07 2012-05-10 Targegen, Inc. Compositions and methods for treating myelofibrosis
US9540395B2 (en) * 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
MY181439A (en) 2011-02-28 2020-12-22 Sunshine Lake Pharma Co Ltd Substituted quinoline compounds and methods of use
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
EP2688883B1 (en) 2011-03-24 2016-05-18 Noviga Research AB Pyrimidine derivatives
EP2508184A1 (en) 2011-04-06 2012-10-10 Æterna Zentaris GmbH Pyridopyrazine derivatives and their use
CN102775356B (zh) * 2011-05-13 2015-07-22 江苏恒谊药业有限公司 4-氨基喹唑啉衍生物及其应用
CN102807526B (zh) * 2011-06-21 2015-12-02 寿光富康制药有限公司 组蛋白去乙酰化酶抑制剂ZYJ-D08a及其差向异构体的制备方法与应用
CN102838625B (zh) * 2011-06-22 2015-04-15 中国科学院上海药物研究所 四氢吡啶并噻唑类化合物、其制备方法、包含该化合物的药物组合物及其用途
CN102276554B (zh) * 2011-06-28 2013-10-30 四川大学 4-（（2-氨基-5-巯基-1,3,4-噻二唑）-甲基）-苯甲酰胺衍生物及其制备方法和用途
WO2013008162A1 (en) * 2011-07-08 2013-01-17 Novartis Ag Novel trifluoromethyl-oxadiazole derivatives and their use in the treatment of disease
TWI574957B (zh) 2011-07-29 2017-03-21 佳佑製藥治療公司 含有醯肼的核運輸調控子及其用途
WO2013019561A1 (en) * 2011-07-29 2013-02-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
JP5966014B2 (ja) * 2011-11-28 2016-08-10 ノバルティス アーゲー 新規トリフルオロメチル−オキサジアゾール誘導体および疾患の処置におけるその使用
JP5881460B2 (ja) * 2012-02-23 2016-03-09 公立大学法人名古屋市立大学 新規アミド化合物及びその用途
JPWO2013137371A1 (ja) * 2012-03-15 2015-08-03 興和株式会社 新規ピリミジン化合物及びそれらを含有する医薬
RS58058B1 (sr) 2012-05-09 2019-02-28 Biogen Ma Inc Modulatori nukleusnog transporta i njihove upotrebe
WO2013184806A1 (en) 2012-06-05 2013-12-12 University Of Kansas Inhibitors of respiratory syncytial virus
BR112015001528B1 (pt) 2012-07-28 2020-12-22 Calitor Sciences, Llc E Sunshine Lake Pharma Co., Ltd. composto, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica
TWI574962B (zh) 2012-11-14 2017-03-21 加拓科學公司 作爲ｐｉ３激酶調節劑的芳雜環化合物及其使用方法和用途
HK1210611A1 (en) 2012-12-21 2016-04-29 Quanticel Pharmaceuticals Inc Histone demethylase inhibitors
US9139583B2 (en) 2013-02-01 2015-09-22 Acetylon Pharmaceuticals, Inc. Selective HDAC3 inhibitors
US9096549B2 (en) 2013-02-01 2015-08-04 Acetylon Pharmaceuticals, Inc. Selective HDAC3 inhibitors
KR102148681B1 (ko) 2013-02-21 2020-08-27 칼리토르 사이언시즈, 엘엘씨 Pi3 키나제 모듈레이터로서의 헤테로방향족 화합물
KR20150132345A (ko) 2013-03-15 2015-11-25 바이오마린 파머수티컬 인크. Hdac 저해제
US10202366B2 (en) 2013-03-15 2019-02-12 Karyopharm Therapeutics Inc. Methods of promoting wound healing using CRM1 inhibitors
DK3010892T3 (en) 2013-06-21 2019-04-15 Karyopharm Therapeutics Inc 1,2,4-TRIAZOLES AS NUCLEAR TRANSPORT MODULATORS AND APPLICATIONS THEREOF
US10046002B2 (en) 2013-08-02 2018-08-14 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
US10561676B2 (en) 2013-08-02 2020-02-18 Syntrix Biosystems Inc. Method for treating cancer using dual antagonists of CXCR1 and CXCR2
US8969365B2 (en) 2013-08-02 2015-03-03 Syntrix Biosystems, Inc. Thiopyrimidinecarboxamides as CXCR1/2 modulators
EP2853532B1 (en) * 2013-09-28 2020-12-09 Instytut Farmakologii Polskiej Akademii Nauk 1,2,4-oxadiazole derivatives as allosteric modulators of metabotropic glutamate receptors belonging to group III
RS59911B1 (sr) 2013-10-14 2020-03-31 Eisai R&D Man Co Ltd Selektivno supstituisana jedinjenja hinolina
CA2920791C (en) 2013-10-14 2021-11-16 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
WO2015058106A1 (en) 2013-10-18 2015-04-23 The General Hospital Corporation Imaging histone deacetylases with a radiotracer using positron emission tomography
US9988343B2 (en) * 2013-11-05 2018-06-05 Dana-Farber Cancer Institute, Inc. Inhibitors of histone deacetylase
US9636298B2 (en) 2014-01-17 2017-05-02 Methylgene Inc. Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
AU2015279719B2 (en) * 2014-06-25 2019-03-21 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
BR112017001918A2 (pt) * 2014-07-31 2017-11-28 Pasteur Institut Korea derivados de 2-amino-benzimidazol e seu uso como inibidores de 5-lipoxigenase e/ou prostaglandina e sintase
KR102608259B1 (ko) 2014-08-15 2023-11-29 카리오팜 쎄라퓨틱스, 인코포레이티드 셀리넥소의 다형태
CA2990660A1 (en) * 2015-07-02 2017-01-05 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
JP6812426B2 (ja) 2015-10-19 2021-01-13 サンシャイン・レイク・ファーマ・カンパニー・リミテッドＳｕｎｓｈｉｎｅ Ｌａｋｅ Ｐｈａｒｍａ Ｃｏ．，Ｌｔｄ． Ｅｇｆｒ阻害剤の塩、結晶形及びその使用
WO2017117535A1 (en) 2015-12-31 2017-07-06 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
EP3397633A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP3456712B1 (en) * 2016-05-12 2022-04-20 Nanjing Shiqi Pharmaceutical Co. Ltd. Novel 2,4,6-trisubstituted s-triazine compound, preparation method therefor, and use thereof
CN106242992A (zh) * 2016-07-25 2016-12-21 北京化工大学 一种苯甲酰胺类化合物及其在制备抑制癌细胞增殖和/或治疗癌症的药物中的应用
CN106496053B (zh) * 2016-09-22 2018-01-05 潍坊医学院 一种组蛋白去乙酰酶抑制剂n‑(2’‑胺基苯基)‑4‑(双(2‑氯乙基)胺基)苯甲酰胺及其制备方法和应用
US10660909B2 (en) 2016-11-17 2020-05-26 Syntrix Biosystems Inc. Method for treating cancer using chemokine antagonists
US11602530B2 (en) 2016-11-28 2023-03-14 Biogen Ma Inc. CRM1 inhibitors for treating epilepsy
TW201829381A (zh) * 2016-12-22 2018-08-16 美商拜奧馬林製藥公司 組蛋白脫乙醯基酶抑制劑
US10357493B2 (en) 2017-03-10 2019-07-23 Selenity Therapeutics (Bermuda), Ltd. Metalloenzyme inhibitor compounds
CN107141244B (zh) * 2017-05-08 2019-11-19 潍坊医学院 吲哚丁酸类组蛋白去乙酰酶抑制剂及其制备方法和应用
KR102576274B1 (ko) * 2017-05-16 2023-09-07 안지 파마슈티컬 코퍼레이션 리미티드 히스톤 데아세틸라제(hdac) 저해제
US11230524B2 (en) * 2017-08-17 2022-01-25 Standard Llc Myocyte enhancer factor 2 (MEF2) modulators
CN107459480A (zh) * 2017-09-05 2017-12-12 镇江斯格派医疗器械有限公司 一种双芳基脲类组蛋白去乙酰化酶抑制剂
KR101964810B1 (ko) 2017-10-12 2019-04-02 충북대학교 산학협력단 Hdac 억제제로서 신규한 퀴나졸린-4(3h)-원 기반 n-하이드록시벤즈아미드 또는 n-하이드록시프로펜아미드 및 이를 유효성분으로 포함하는 항암제 조성물
US12133852B2 (en) 2017-11-15 2024-11-05 Epivario, Inc. ACSS2 inhibitors and methods of use thereof
EP3710430B9 (en) 2017-11-15 2024-10-30 Metabomed Ltd Acss2 inhibitors and methods of use thereof
CN108570012B (zh) * 2018-05-23 2021-11-12 中南大学 1,3-苯并噁嗪-2,4(3h)-二酮衍生物及其合成方法和用途
CN109020951B (zh) * 2018-08-24 2020-06-02 大连理工大学 含三取代三聚氯氰的萘酰亚胺类衍生物及其合成方法和应用
CN109336870A (zh) * 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 咔唑类stat3抑制剂晶型i及其制备方法
CN110078722A (zh) * 2018-10-31 2019-08-02 南京先进生物材料与过程装备研究院有限公司 一种噻吨酮类stat3抑制剂马来酸盐晶型a及其应用
CN109336871A (zh) * 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种stat3抑制剂的马来酸盐及其制备方法与用途
CN109369628A (zh) * 2018-10-31 2019-02-22 南京先进生物材料与过程装备研究院有限公司 咔唑类stat3抑制剂晶型ii及其制备方法
CN109180656A (zh) * 2018-10-31 2019-01-11 南京先进生物材料与过程装备研究院有限公司 一类stat3抑制剂及其应用
CN109336876A (zh) * 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 二苯并[b,d]噻吩类STAT3抑制剂的酒石酸盐及其制备方法与用途
CN109369626A (zh) * 2018-10-31 2019-02-22 南京先进生物材料与过程装备研究院有限公司 咔唑类stat3抑制剂p晶型及其制备方法
CN109336869A (zh) * 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 一种stat3抑制剂的甲磺酸盐及其制备方法与用途
CN109336877A (zh) * 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 二苯并[b,d]噻吩类STAT3抑制剂的甲磺酸盐及其制备方法与用途
CN109336867A (zh) * 2018-10-31 2019-02-15 南京先进生物材料与过程装备研究院有限公司 咔唑类stat3抑制剂晶型a及其制备方法
CN109293647A (zh) * 2018-10-31 2019-02-01 南京先进生物材料与过程装备研究院有限公司 二苯并[b,d]噻吩类STAT3抑制剂的M晶型及其制备方法
CA3136083A1 (en) * 2019-05-14 2020-11-19 Metabomed Ltd Acss2 inhibitors and methods of use thereof
GB201918404D0 (en) * 2019-12-13 2020-01-29 Z Factor Ltd Compounds and their use for the treatment of aplha1-antitrypsin deficiency
CN111116469A (zh) * 2019-12-27 2020-05-08 北京鑫开元医药科技有限公司 一种hdac抑制剂、制备方法、药物组合物及其用途
CN113549057B (zh) * 2020-04-24 2023-01-31 中国药科大学 Snail抑制剂及其衍生物，制备方法、药物组合物和应用
CN115403483B (zh) * 2021-07-02 2024-01-26 河南省儿童医院郑州儿童医院 含二苯乙烯或二苯甲酮骨架的ca-4衍生物、药物组合物及其制备方法和应用
CN114539180B (zh) * 2021-12-24 2025-02-07 贵州大学 一种含异噁唑啉的双酰胺类化合物及其制备方法和用途
CN118745163A (zh) * 2024-06-06 2024-10-08 四川省医学科学院·四川省人民医院 苯并呋喃类化合物、其制备方法及其应用和pdgfr激酶抑制剂

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE623069C (de) 1931-11-07 1935-12-12 I G Farbenindustrie Akt Ges Verfahren zur Herstellung von Aminoacylaminoanthrachinonen
US2598587A (en) 1949-07-22 1952-05-27 Ciba Ltd Di (1, 4 diamino-2-aryl ketone anthraquinone) amides of aromatic dicarboxylic acids
GB680857A (en) 1949-07-22 1952-10-15 Ciba Ltd Manufacture of vat dyestuffs of the anthraquinone series
US2754286A (en) * 1951-10-15 1956-07-10 Du Pont Aldehydes and their acetals
FR1071798A (fr) 1952-04-12 1954-09-06 Basf Ag Procédé pour la production de dérivés d'acides 1-aminoanthraquinones-2-carboxyliques
CH431764A (de) 1959-05-06 1967-03-15 Sandoz Ag Verfahren zur Herstellung metallhaltiger Reaktivfarbstoffe
DE1164003B (de) 1961-08-05 1964-02-27 Bayer Ag Verfahren zur Herstellung von Anthrachinonfarbstoffen
US3329700A (en) 1962-02-15 1967-07-04 Polaroid Corp (dihydroxy- and dicarbethoxy-phenyl) phenylcarboxamide compounds
BE630205A (OSRAM) 1963-03-28
US3263924A (en) 1963-09-13 1966-08-02 Dole Valve Co Heating and cooling zone valve
IL22272A (en) 1963-11-06 1969-02-27 Merck & Co Inc 2-heteroaryl-5(or 6)-aryl substituted benzazoles
US3376268A (en) 1964-02-26 1968-04-02 Monsanto Co Amide-heterocyclic polymers
US3336286A (en) 1964-06-25 1967-08-15 Du Pont 5-nitro-2-thiazole-3'-amino arylcarbonyl and arylsulfonyl anilide azo dyes
GB1147769A (en) 1965-09-30 1969-04-10 Monsanto Co Polymerization of aromatic primary diamines
CH477163A (de) 1967-07-26 1969-10-15 Ciba Geigy Verwendung von Salicylsäure-o-hydroxyphenylamiden zum antimikrobiellen Ausrüsten bzw. zum Schützen von textilem Material gegen schädliche Mikroorganismen
FR2036652A5 (en) 1969-03-06 1970-12-24 Ciba Geigy Naphthoxazole optical blueing agents
US3637534A (en) 1969-07-09 1972-01-25 Monsanto Co Polymers from aromatic primary diamines
DE2019427A1 (de) 1970-04-22 1971-11-11 Bayer Ag 1-Arylamino-2-hydroxy-anthrachinone und Verfahren zu ihrer Herstellung
CH554890A (de) 1970-12-31 1974-10-15 Sandoz Ag Verfahren zur herstellung von bistriazolverbindungen.
FR2128369A1 (en) 1971-03-03 1972-10-20 Ciba Geigy Ag Anthraquinone/acridone vat dyes - and pigments contg triazine grps for cellulosic fibres, plastics, paints, etc
CH559737A5 (en) 1971-09-28 1975-03-14 Sandoz Ag Bis-ar-oxazolyl-para-poly-phenylenes, prodn. - from di-carboxylic acid and ortho-amino-hydroxy cpds. and use as optical brighteners
LU76467A1 (OSRAM) 1976-12-23 1978-07-10
DE2846168A1 (de) 1978-10-24 1980-05-08 Bayer Ag Verfahren zum faerben und bedrucken von cellulosefasern
JPS60126832A (ja) 1983-12-14 1985-07-06 Hitachi Ltd ドライエツチング方法および装置
IT1196348B (it) 1984-11-29 1988-11-16 Italfarmaco Spa Composti ad attivita'antiinfiammatoria
LU86022A1 (fr) 1985-07-25 1987-02-04 Cird Derives aromatiques polycyliques,leur procede de preparation et leur application dans les domaines pharmaceutique et cosmetique
NZ219974A (en) 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
JPS63111400A (ja) 1986-10-28 1988-05-16 Tokyo Gas Co Ltd 地下式低温貯槽の側壁上部構造
US5149797A (en) 1990-02-15 1992-09-22 The Worcester Foundation For Experimental Biology Method of site-specific alteration of rna and production of encoded polypeptides
JPH03258749A (ja) 1990-03-07 1991-11-19 Ono Pharmaceut Co Ltd ベンゾフェノン誘導体、それらの製造方法、およびそれらを含有する薬剤
US5149755A (en) 1991-07-05 1992-09-22 Eastman Kodak Company Preparation of poly(benz(ox, imid, thi)azole) polymers
US5332750A (en) 1991-09-04 1994-07-26 Merck Patent Gesellschaft Mit Beschrankter Haftung 1,2-dihydro-2-oxopyridines
DK0533268T3 (da) 1991-09-18 2001-12-03 Glaxo Group Ltd Benzanilidderivater som 5HT-1D antagonister
RU2027701C1 (ru) 1992-01-03 1995-01-27 Акционерное общество открытого типа "Научно-исследовательский и проектный институт мономеров с опытным заводом" N,n`-бис-(2,4-диаминофенил)амиды 4,4`-дифенил- или 4,4`-дифенилоксид дикарбоновой кислоты в качестве промежуточных продуктов в синтезе 4,4`-бис [5(6)-аминобензимидазолил-2]-дифенила или -дифенилоксида
US5652355A (en) 1992-07-23 1997-07-29 Worcester Foundation For Experimental Biology Hybrid oligonucleotide phosphorothioates
JPH06128276A (ja) 1992-10-20 1994-05-10 Canon Inc 液晶性化合物、これを含む液晶組成物、それを有する液晶素子、それらを用いた表示方法および表示装置
DE4339868A1 (de) 1993-11-23 1995-05-24 Merck Patent Gmbh Imidazopyridazine
US6162815A (en) * 1994-04-26 2000-12-19 Centre International De Recherches Dermatologiques Galderma RXR-agonist polycyclic aromatic compounds, pharmaceutical/cosmetic compositions comprising said compound and uses thereof
CN1048239C (zh) 1994-05-31 2000-01-12 帝人株式会社 萘衍生物
DE19510957A1 (de) 1995-03-25 1996-09-26 Huels Chemische Werke Ag Eingedickter Bodenverfestiger, sowie diesen enthaltende verpackte Fertigmischung für Bodenbehandlungen
FR2733684B1 (fr) 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
US6777217B1 (en) 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
JP3354090B2 (ja) * 1996-09-30 2002-12-09 シエーリング アクチエンゲゼルシャフト 分化誘導剤
US6794392B1 (en) 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
JPH10219128A (ja) 1997-02-06 1998-08-18 Mitsui Chem Inc 新規アントラキノン化合物及びその用途
WO1998042672A1 (en) * 1997-03-24 1998-10-01 Kyowa Hakko Kogyo Co., Ltd. Benzene derivatives
FR2761986B1 (fr) 1997-04-09 1999-05-21 Hoechst Schering Agrevo Sa Nouveaux amides aromatiques, leur procede de preparation et leur application comme pesticides
JP4669590B2 (ja) 1997-05-14 2011-04-13 富士フイルム株式会社 ビスベンゾアゾール化合物
FR2767525B1 (fr) 1997-08-21 1999-11-12 Cird Galderma Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
JP3355292B2 (ja) 1997-08-25 2002-12-09 大日精化工業株式会社 複写防止記録方法
US6034251A (en) 1997-11-07 2000-03-07 Schering Corporation Phenyl-alkyl-imidazoles
JPH11318492A (ja) 1998-03-09 1999-11-24 Aisin Seiki Co Ltd 蛍光発生性基質を含有する組成物
JPH11269146A (ja) 1998-03-24 1999-10-05 Mitsui Chem Inc 分化誘導剤
JP2003521446A (ja) 1998-07-20 2003-07-15 スミスクライン・ビーチャム・コーポレイション マクロファージスカベンジャー受容体アンタゴニスト
EP1098892A1 (en) 1998-07-20 2001-05-16 MERCK PATENT GmbH Biphenyl derivatives
JP3753293B2 (ja) 1998-08-07 2006-03-08 富士写真フイルム株式会社 有機エレクトロルミネッセンス素子
SG104255A1 (en) 1998-09-29 2004-06-21 Sumitomo Bakelite Co Polybenzoxazole resin and precursor thereof
JP2000178356A (ja) 1998-12-17 2000-06-27 Sumitomo Bakelite Co Ltd ポリベンゾオキサゾール前駆体及びポリベンゾオキサゾール樹脂
JP4524808B2 (ja) 1999-03-30 2010-08-18 日立化成デュポンマイクロシステムズ株式会社 感光性樹脂組成物、レリーフパターンの製造法
JP2000290374A (ja) 1999-04-09 2000-10-17 Central Glass Co Ltd 含フッ素ポリベンゾオキサゾール
US6653309B1 (en) 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
JP4399949B2 (ja) 1999-06-29 2010-01-20 日立化成デュポンマイクロシステムズ株式会社 感光性樹脂組成物、パターンの製造法及び電子部品
JP2001011181A (ja) 1999-07-02 2001-01-16 Sumitomo Bakelite Co Ltd 絶縁材用樹脂組成物及びこれを用いた絶縁材
JP2001035256A (ja) 1999-07-23 2001-02-09 Sumitomo Bakelite Co Ltd 絶縁材用組成物及びこれを用いた絶縁材
JP2001081031A (ja) 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
JP2001139684A (ja) 1999-08-30 2001-05-22 Sumitomo Bakelite Co Ltd 多層配線用層間絶縁膜並びにそれに用いる樹脂及びその製造方法
DE60040676D1 (de) 1999-09-17 2008-12-11 Millennium Pharm Inc BENZAMIDE UND ÄHNLICHE INHIBITOREN VON FAKTOR Xa
US6632815B2 (en) 1999-09-17 2003-10-14 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
JP2001114893A (ja) 1999-10-15 2001-04-24 Sumitomo Bakelite Co Ltd ポリベンゾオキサゾール樹脂およびその前駆体
JP4360660B2 (ja) 1999-11-09 2009-11-11 三井化学株式会社 モノアシルフェニレンジアミン誘導体の精製法
US6541661B1 (en) * 1999-11-23 2003-04-01 Methylgene, Inc. Inhibitors of histone deacetylase
AU3408901A (en) 2000-02-15 2001-08-27 Teijin Ltd Cancer remedy comprising anthranilic acid derivative as active ingredient
CA2401778C (en) 2000-02-29 2010-12-21 Cor Therapeutics, Inc. Benzamides and related inhibitors of factor xa
AU2001241128A1 (en) * 2000-03-14 2001-09-24 Fujisawa Pharmaceutical Co. Ltd. Novel amide compounds
WO2003006652A2 (en) 2000-03-24 2003-01-23 Methylgene, Inc. Inhibition of specific histone deacetylase isoforms
ATE489360T1 (de) 2000-03-24 2010-12-15 Methylgene Inc Inhibitoren der histon-deacetylase
US7122544B2 (en) * 2000-12-06 2006-10-17 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
KR20040018328A (ko) 2001-01-12 2004-03-03 메틸진, 인크. 히스톤 디아세틸라제-4를 특이적으로 억제하는 방법
US7067539B2 (en) 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
US7507767B2 (en) 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
CA2465978C (en) 2001-09-14 2015-04-07 Soon Hyung Woo Inhibitors of histone deacetylase
US6897220B2 (en) 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
US7868204B2 (en) 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
WO2003042174A1 (en) 2001-11-14 2003-05-22 Schering Corporation Cannabinoid receptor ligands
JP4169986B2 (ja) 2001-11-26 2008-10-22 日本曹達株式会社 フェノール性化合物及びそれを用いた記録材料
PL205531B1 (pl) 2002-03-13 2010-04-30 Janssen Pharmaceutica Nv Pochodna karbonyloaminowa, jej zastosowanie i sposób wytwarzania oraz kompozycja farmaceutyczna
OA12790A (en) 2002-03-13 2006-07-10 Janssen Pharmaceutica Nv New inhibitors of histone deacetylase.
CN1305850C (zh) 2002-03-13 2007-03-21 詹森药业有限公司 作为组蛋白脱乙酰酶新颖抑制剂的磺酰基氨基衍生物
EA006707B1 (ru) 2002-03-13 2006-02-24 Янссен Фармацевтика Н. В. Сульфонилпроизводные в качестве новых ингибиторов гистон-деацетилазы
AU2003218735B2 (en) 2002-03-13 2009-03-12 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
CN100451001C (zh) 2002-03-14 2009-01-14 日本曹达株式会社 酚性化合物及使用酚性化合物的记录材料
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0209715D0 (en) 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
CA2487346A1 (en) 2002-06-19 2003-12-31 Schering Corporation Cannabinoid receptor agonists
US20040072770A1 (en) 2002-07-03 2004-04-15 Besterman Jeffrey M. Methods for specifically inhibiting histone deacetylase-7 and 8
KR20050074487A (ko) 2002-10-17 2005-07-18 메틸진, 인크. 히스톤 데아세틸라아제의 억제제
WO2004048322A1 (en) 2002-11-25 2004-06-10 Schering Corporation Cannabinoid receptor ligands
WO2004058234A2 (en) 2002-12-27 2004-07-15 Schering Aktiengesellschaft Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors
US7208491B2 (en) 2003-02-07 2007-04-24 Hoffmann-La Roche Inc. N-monoacylated o-phenylenediamines
US7244751B2 (en) 2003-02-14 2007-07-17 Shenzhen Chipscreen Biosciences Ltd. Histone deacetylase inhibitors of novel benzamide derivatives with potent differentiation and anti-proliferation activity
AR043633A1 (es) 2003-03-20 2005-08-03 Schering Corp Ligandos de receptores de canabinoides
WO2005030705A1 (en) 2003-09-24 2005-04-07 Methylgene, Inc. Inhibitors of histone deacetylase
WO2005092899A1 (en) 2004-03-26 2005-10-06 Methylgene Inc. Inhibitors of histone deacetylase
US7253204B2 (en) 2004-03-26 2007-08-07 Methylgene Inc. Inhibitors of histone deacetylase
JP2008540574A (ja) 2005-05-11 2008-11-20 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
JP5554988B2 (ja) 2006-04-07 2014-07-23 メチルジーン インコーポレイテッド ヒストンデアセチラーゼの阻害剤

Similar Documents

Publication Publication Date Title
JP2005508905A5 (OSRAM)
JP2007510619A5 (OSRAM)
JP2006526031A5 (OSRAM)
JP2005518413A5 (OSRAM)
JP2004516314A5 (OSRAM)
WO2005046589A3 (en) Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
JP2010511721A5 (OSRAM)
JP2006514012A5 (OSRAM)
JP2003531118A5 (OSRAM)
JP2002543183A5 (OSRAM)
JP2006514626A5 (OSRAM)
JP2007522220A5 (OSRAM)
JP2003503449A5 (OSRAM)
JP2009515872A5 (OSRAM)
JP2005508962A5 (OSRAM)
EP2308828A3 (en) CaSR antagonist
JP2007520440A5 (OSRAM)
JP2005527542A5 (OSRAM)
JP2007519618A5 (OSRAM)
JP2006508979A5 (OSRAM)
JPH10287651A5 (OSRAM)
JP2008513510A5 (OSRAM)
JP2006523698A5 (OSRAM)
CA2382581A1 (en) Substituted benzylthiazolidine-2,4-dione derivatives
RU2004117595A (ru) Производные пиридина в качестве лигандов рецептора nmda